Starting Mounjaro at 5mg for weight loss: what the evidence says

What the SURMOUNT-1 trial tells us about dose and results

The headline figures from SURMOUNT-1 (average body-weight reductions of around 20–21% at the 15mg maintenance dose over 72 weeks) were not achieved at any single dose in isolation. Participants in the trial followed a structured escalation, beginning at a low dose and moving upward under supervision. The SURMOUNT-1 paper published in the New England Journal of Medicine describes how tolerability was built into the study design from the start. Results at lower doses, including 5mg, were meaningful but more modest; the larger losses accumulated as participants reached and stayed at their highest tolerated dose over time. That is the context in which any dose figure should be read.

The clinical implication is straightforward: 5mg is not a weak dose, but it is the second step, not the destination for most people. Prescribers use it as the first real therapeutic dose once the 2.5mg phase has settled the digestive system. If you are wondering whether starting Mounjaro at 5mg is an option, it is worth understanding that doing so bypasses the phase whose specific job is to reduce early nausea and vomiting, and those side effects can be the main reason people stop treatment before it has a chance to work.

Why the 2.5mg phase exists, and what happens if you skip it

Tirzepatide slows gastric emptying significantly, which is one of the reasons it reduces appetite. That same mechanism is responsible for the nausea, vomiting and diarrhoea that some people notice in the early weeks. The 2.5mg dose is calibrated to begin that adaptation at a level the gut can tolerate; it is not a therapeutic dose in the weight-loss sense, but it performs a real clinical function. The NHS tirzepatide page explains that the dose is increased gradually to reduce the chance of side effects, this is not a formality.

Beginning at 5mg compresses that adjustment window. For some people the difference might be minor; for others, the GI impact is enough to make the early weeks genuinely unpleasant. Either way, it falls outside the licensed and evidence-based starting point, which means a responsible prescriber will not agree to it without a specific clinical reason. If you are curious whether staying at a lower dose longer is right for you, our page on staying on 2.5mg Mounjaro covers that question directly.

What a prescriber actually considers when setting your dose

Dose decisions are not mechanical. A GPhC-registered Independent Prescriber looks at your full clinical picture: any existing conditions, medicines you take, how your body responded to the previous dose, and whether you are losing weight at the current level. Someone who found 2.5mg genuinely difficult (persistent nausea, significant diarrhoea) might have their titration slowed, staying at 2.5mg for eight weeks rather than four. Someone who tolerated it easily would typically move to 5mg on schedule.

For people who have already been on Mounjaro elsewhere and are transferring to a new provider, the question of which dose to continue on is part of the evidence review any responsible pharmacy should carry out. Our page on Mounjaro dosing for weight loss goes into the full dose range and how increases work in practice. The cost of treatment at different dose levels is covered on our Mounjaro cost page, since the price per four-week pen does vary by strength.

The short answer, practically speaking

If you are new to Mounjaro, you will start at 2.5mg. That is the licensed starting point, it is what NICE's appraisal of tirzepatide (TA1026) is built around, and it is what every GPhC-registered prescriber will follow. The 5mg dose is where most people move after four weeks, and if you are asking whether staying on 5mg Mounjaro is a viable long-term approach, it marks the beginning of the active therapeutic phase for many, with results from the clinical programme starting to become meaningful from this point onward.

There is no shortcut through titration that improves outcomes. The evidence base was built on the schedule as written. If you are wondering whether Mounjaro is right for you at all, a good place to begin is our overview of how Mounjaro works, or you can read about the broader range of weight-loss treatment options we offer. One practical note: orders placed by 12pm on weekdays are dispatched the same day once approved, worth bearing in mind if you are planning around a bank holiday or a busy week.

When you are ready, a free consultation with our prescribers is the natural next step. They review every case personally, a real clinician reads your answers the same day, not an automated queue. Start your free consultation and they will confirm which dose is right for you from the beginning.